Benzinga | Aug 10, 2020 11:12AM EDT

Earnings Preview for Sunesis Pharmaceuticals

Sunesis Pharmaceuticals (NASDAQ: SNSS) will be releasing its next round of earnings this Tuesday, August 11. For all of the relevant information, here is your guide for Tuesday's Q2 earnings announcement.

Earnings and Revenue

Sunesis Pharmaceuticals EPS is expected to be around $-0.06, according to sell-side analysts. Sales will likely be near $190.00 thousand. In the same quarter last year, Sunesis Pharmaceuticals posted EPS of $-0.09. The analyst consensus estimate would represent a 33.33% increase in the company's earnings. Here's how the company's reported EPS has stacked up against analyst estimates in the past:

Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019EPS Estimate -0.07 -0.07 -0.08 -0.10EPS Actual -0.05 -0.05 -0.06 -0.09Revenue Estimate 190.00 K 310.00 K 200.00 K 150.00 KRevenue Actual 120.00 K 2.07 M 0 0

Stock Performance

Over the last 52-week period, shares are down 57.29%. Given that these returns are generally negative, long-term shareholders are probably upset going into this earnings release.

Don't be surprised to see the stock move on comments made during its conference call. Sunesis Pharmaceuticals is scheduled to hold the call at 16:30:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/6hztwkz9